Yangxin Fu

Title: Innovations of Yangxin Fu

Introduction

Yangxin Fu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). With a total of 4 patents, his work has the potential to impact cancer treatment and immunotherapy.

Latest Patents

Yangxin Fu's latest patents include groundbreaking innovations. One of his notable patents is titled "Chimeric antigen receptor and use thereof." This patent describes a CAR that includes a targeting moiety, a transmembrane domain, a co-stimulatory domain, and an intracellular signaling domain. The targeting moiety specifically binds to variable regions Vα and Vβ of a T cell receptor (TCR) and/or fragments thereof. Another significant patent is "Universal CAR-T cell and preparation method and use thereof." This patent discloses a universal CAR-T cell that knocks out one or more of CD3 delta, CD3 gamma, CD3 epsilon, and CD3 zeta, while simultaneously introducing the HSV-TK gene. It also details a method for preparing the CAR-T cell and its various applications.

Career Highlights

Yangxin Fu has worked with notable organizations, including Shanghai Longyao Biotechnology Inc., Ltd. and Shanghai Jiaotong University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in biotechnology.

Collaborations

Yangxin Fu has collaborated with several professionals, including Xuanming Yang and Xin Wang. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yangxin Fu is a distinguished inventor whose work in chimeric antigen receptors is paving the way for innovative cancer therapies. His contributions to biotechnology are significant and continue to influence the field.